PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery
Recruiting now · Phase 4
Conditions studied: Hip Disease, Hip Dysplasia, Hip Arthropathy
In brief
This randomized controlled trial (RCT) compares the analgesic effectiveness of two regional anesthesia techniques-Pericapsular Nerve Group (PENG) block combined with Lateral Femoral Cutaneous Nerve Block (LFCB) versus Lumbar and Sacral Erector Spinae Plane Blocks (L-ESPB and S-ESPB)-in pediatric patients undergoing hip surgery.
Key facts
- Study ID
- NCT07023094
- Run by
- Poznan University of Medical Sciences
- People needed
- 60
- Starts
- 2025-06-16
- Expected to finish
- 2026-06-30
- Last updated by the study team
- 2025-07-11
Who can join
Age: 2 and older, up to 16. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Pediatric patients aged between 2 and 16 years.
- Scheduled for elective orthopedic hip surgery, including: Osteotomies and Hip reconstruction surgeries
- ASA (American Society of Anesthesiologists) physical status classification: I-III.
- Written informed consent obtained from the patient's legal guardian(s).
You may not qualify if…
- Known allergy or hypersensitivity to any of the study medications
- Presence of infection or inflammation at the intended injection site(s) of regional anesthesia.
- Coagulopathy or bleeding disorders (including patients on anticoagulant therapy) that contraindicate nerve blocks.
- Neurological disorders or peripheral neuropathies that could influence sensory or motor assessment of the lower limbs.
- Cognitive impairment or behavioral disorders significantly affecting pain assessment accuracy or cooperation.
- History of chronic opioid use or known substance abuse.
- Severe systemic disease or condition compromising patient safety or interfering with study protocol adherence.
Where it is running
- Poznan University of Medical Sciences — Poznan, Poland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.